Literature DB >> 23510469

TrkB expression level correlates with metastatic properties of L1 mouse sarcoma cells cultured in non-adhesive conditions.

J Miłoszewska1, M Przybyszewska, M Gos, P Swoboda, H Trembacz.   

Abstract

OBJECTIVES: Ability of a cell to survive without adhesion, and to overcome anoikis, is indispensable for malignant cell invasion and metastasis formation. It has previously been shown that TrkB -neutrophin growth factor receptor might be involved in suppression of apoptosis, induced by the lack of adhesion. The aim of our study was to analyse changes in expression of genes and proteins as well as in biological properties of cancer cells cultured without adhesion. A mouse sarcoma, stable, adherent L1 cell line, derived from a spontaneously arisen Balb/c mouse lung tumour, was established in vitro.
MATERIALS AND METHODS: L1 cells resistant to anoikis were established by culture of L1 cells without adhesion, followed by selection of clones with elevated expression levels of TrkB protein. Biological characteristics of the cells were studied by migration/invasion tests and colony forming assay. Gene expression analysis was performed by with the aid of cDNA Gene Expression Array and Real-Time PCR. In vivo experiments were conducted in syngeneic Balb/c mice.
RESULTS: Significant changes in gene expression, including higher expression level of TrkB, were found in cells that were able to survive without adhesion. Selected TrkB-expressing clones were found to have higher clonogenicity and invasive potential, formed more colonies in mouse lungs, and induced larger tumours, when injected subcutaneously into Balb/c mice.
CONCLUSION: Lack of adhesion induced significant changes in the cancer cells' behaviour, which may result from alterations in gene and protein expression levels, including changes in anoikis-connected protein - TrkB.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23510469      PMCID: PMC6496513          DOI: 10.1111/cpr.12015

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  22 in total

Review 1.  On Trk--the TrkB signal transduction pathway is an increasingly important target in cancer biology.

Authors:  Carol J Thiele; Zhijie Li; Amy E McKee
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

2.  A new in vitro assay for quantitating tumor cell invasion.

Authors:  L A Repesh
Journal:  Invasion Metastasis       Date:  1989

3.  Mouse sarcoma L1 cell line holoclones have a stemness signature.

Authors:  J Miloszewska; M Gos; M Przybyszewska; H Trembacz; M Koronkiewicz; P Janik
Journal:  Cell Prolif       Date:  2010-06       Impact factor: 6.831

4.  Role and relevance of TrkB mutations and expression in non-small cell lung cancer.

Authors:  Taishi Harada; Yasushi Yatabe; Masafumi Takeshita; Takaomi Koga; Tokujiro Yano; Yisong Wang; Giuseppe Giaccone
Journal:  Clin Cancer Res       Date:  2011-01-17       Impact factor: 12.531

5.  Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells.

Authors:  Katsuya Nakamura; Kelly C Martin; Jennifer K Jackson; Kiichiro Beppu; Chan-Wook Woo; Carol J Thiele
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

6.  Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer.

Authors:  Xiaohui Yu; Ling Liu; Bin Cai; Yinyan He; Xiaoping Wan
Journal:  Cancer Sci       Date:  2008-01-14       Impact factor: 6.716

7.  Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB.

Authors:  Sirith Douma; Theo Van Laar; John Zevenhoven; Ralph Meuwissen; Evert Van Garderen; Daniel S Peeper
Journal:  Nature       Date:  2004-08-26       Impact factor: 49.962

8.  Implications of tropomyosin-related kinase B (TrkB) in head and neck cancer.

Authors:  Li Zhu; Jochen A Werner; Robert Mandic
Journal:  Anticancer Res       Date:  2007 Sep-Oct       Impact factor: 2.480

9.  Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1.

Authors:  Shogo Ehata; Aki Hanyu; Makoto Hayashi; Hiroyuki Aburatani; Yukio Kato; Makoto Fujime; Masao Saitoh; Keiji Miyazawa; Takeshi Imamura; Kohei Miyazono
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

10.  Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome.

Authors:  Christy W H Au; Michelle K Y Siu; Xiaoyun Liao; Esther S Y Wong; Hextan Y S Ngan; Kar Fai Tam; Dominic C W Chan; Queeny K Y Chan; Annie N Y Cheung
Journal:  Cancer Lett       Date:  2009-08-28       Impact factor: 8.679

View more
  3 in total

Review 1.  Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies.

Authors:  Jing Wang; Zhijie Luo; Lizhu Lin; Xinbing Sui; Lili Yu; Cong Xu; Ruonan Zhang; Ziming Zhao; Qianru Zhu; Bo An; Qiao Wang; Bi Chen; Elaine Lai-Han Leung; Qibiao Wu
Journal:  Cancers (Basel)       Date:  2022-09-30       Impact factor: 6.575

2.  Novel pharmacologic targeting of tight junctions and focal adhesions in prostate cancer cells.

Authors:  Patrick J Hensley; Andreas Desiniotis; Chi Wang; Arnold Stromberg; Ching-Shih Chen; Natasha Kyprianou
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

3.  Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer.

Authors:  Daniel Richard Gomez; Lauren Averett Byers; Monique Nilsson; Lixia Diao; Jing Wang; Lerong Li; Pan Tong; Mia Hofstad; Babita Saigal; Ignacio Wistuba; Neda Kalhor; Stephen Swisher; Youhong Fan; Waun Ki Hong; Milind Suraokar; Carmen Behrens; Cesar Moran; John Victor Heymach
Journal:  Oncotarget       Date:  2018-01-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.